ArticlePharmacological reports : PR2026

The anti-CEACAM1 agonistic antibody CCM5.01 inhibits the growth of colon cancer cell lines in 2D and 3D models.

Shiran Niazov et al.PubMed ↗Publisher ↗

No numbers read from the abstract.